MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617091232 A) filed by Seagen Inc. on July 27, 2026, for Methods Of Treating Cancers Using Anti-Cd30 Antibody-Drug Conjugates.
Inventor includes Chen, Tara L..
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: Provided herein are antibody-drug conjugates that bind to CD30 comprising an anti-CD30 antibody or an antigen-binding fragment thereof and methods of using the same to treat cancer in a subject.
Disclaimer: Curated by HT Syndication....